News

Ambassador Eric Goosby MD announced as new Chair of the Global TB/HIV Working Group
14 Feb 2014

Ambassador Eric Goosby, MD was announced as the new Chair of the Global TB/HIV Working Group at the 19th Core Group meeting held in Washington on 11-12 February 2014. Having stepped down from his position as United States Global AIDS Coordinator (2009-2013) where he led all US Government international HIV efforts, he is currently heading a new centre on implementation science at University of California, San Francisco’s Global Health Sciences. Ambassador Goosby’s 30 years of experience in HIV began at San Francisco General Hospital; he became associate medical director of the AIDS Clinic in 1987. During the Clinton administration, he served as Deputy Director of the White House National Policy Office and Director of the Office of HIV/AIDS Policy of the US Department of Health and Human Services. From 2001 until 2009, Ambassador Goosby was CEO and Chief Medical Officer of Pangaea Global AIDS Foundation, playing a key role in the development and implementation of HIV/AIDS national treatment scale-up plans in Rwanda, South Africa, China, and Ukraine.

As US Global AIDS Coordinator, he worked hard to advance the TB/HIV agenda, improve its visibility and ensure its prominence in the PEPFAR Blue Print for an AIDS Free Generation. He has also served on the Board of the Global Fund, representing the US Government. Ambassador Goosby’s new appointment offers an ideal opportunity to further enhance the global TB/HIV response and optimise coordination and action between key TB and HIV stakeholders to catalyse and intensify country level scale-up.

19th Core Group Meeting of the Global TB/HIV Working Group
11 Feb 2014

11-12 February 2014 | Washington DC, USA

The World Health Organization convened the 19th Core Group meeting of the Global TB/HIV Working Group from 11th - 12th February 2014 in Washington DC. The meeting was co-chaired by Diane Havlir, the outgoing Chair of the Global TB/HIV Working Group and Ambassador Eric Goosby the new incoming Chair. Meeting participants critically reviewed the past ten years of global progress in implementation and science in preventing, diagnosing and treating HIV-associated TB. They also identified essential next steps including enablers for advancing the TB/HIV response particularly at country level to eliminate TB deaths among people living with HIV. Innovative ideas to address unmet research needs in prevention, diagnosis and treatment of TB among people living with HIV were also shared for shaping the global research agenda. The detailed agenda and presentations can be found at the links below and a more detailed report will be posted up in due course.

Core Group Agenda | Meeting Report and Presentations

Regional TB/HIV Implementation Workshop and 18th Core Group Meeting of the Global TB/HIV Working Group
12 Apr 2013

10-12 April 2013 | Maputo, Mozambique

The World Health Organization, supported by the President's Emergency Plan for AIDS Relief (PEPFAR), convened a regional TB/HIV Implementation Workshop followed by the 18th Core Group meeting of the TB/HIV Working Group of the Stop TB Partnership from 10th - 12th April 2013 in Maputo, Mozambique. The event brought together more than 120 participants, comprising key international partners as well as regional and national HIV and TB stakeholders including community and civil society representatives from 14 countries in the African region. Countries represented included Botswana, Ethiopia, Kenya, Lesotho, Malawi, Mozambique, Namibia, Nigeria, South Africa, Swaziland, Uganda, United Republic of Tanzania, Zambia, and Zimbabwe. The aim of the workshop was to review progress in implementation and promote strategies to increase access to early ART for people living with HIV and active TB and to accelerate the scale-up of the Three Is for HIV/TB in the African Region. Participants also shared best practices and identified priority actions for scaling up, and monitoring and evaluating the implementation of collaborative TB/HIV activities.

The aim of the 18th Core Group Meeting, which was also attended by participants of the regional meeting and members of the Core Group was to assess the latest evidence, identify challenges and opportunities to eliminate TB deaths among people living with HIV. The meeting also discussed strategies to define the direction of the TB/HIV Working Group over the coming years. For more details please visit the links below. Reports of both meetings will be posted below in due course.

Core Group agenda | Core Group Meeting report | Presentations | Workshop agenda | Workshop report

Message from the Chair and Secretariat of the TB/HIV Working Group
1 Apr 2013

For a brief overview of activities carried out by the Secretariat and the Working Group, and events planned for the coming months, please read the latest "Message from the Chair and the Secretariat" on our TB/HIV Updates page.

HIV/TB Research Meeting and TB/HIV Coverage at CROI 2013
3 Mar 2013

3-6 March, 2013 | Atlanta, Georgia, USA

The World Health Organization and the Consortium to Respond Effectively to the AIDS/TB Epidemic (CREATE) convened their 7th CROI-affiliated HIV/TB research meeting on behalf of the TB/HIV Working Group of the Stop TB Partnership in Atlanta, Georgia USA on 3 March, 2013. The meeting discussed critical knowledge and research gaps on TB prevention among children and adults and drug interactions between new TB drugs and ART. Attended by some 100 participants, the meeting was convened by Dr Haileyesus Getahun of WHO and co-chaired by Dr Diane Havlir of UCSF and Chair of the Global TB/HIV Working Group and Dr Richard Chaisson, of Johns Hopkins and Director of CREATE.

Thanks to efforts by Working Group and Core Group members over the years in raising the profile of TB/HIV at CROI, there was a record number of abstracts at the main CROI conference this year including late breakers on TB and one full day of TB discussions as well as increased mainstreaming of TB discussions in all the critical areas of HIV care including basic science. For more details on the HIV/TB Research meeting and for a brief summary with links to the key TB-related studies presented, please visit the following link.

TB/HIV at AIDS 2012, XIX International AIDS Conference
27 Jul 2012

22-27 July, 2012 | Washington DC, USA

Thanks to efforts of the TB/HIV Core Group and Working Group and with the strong support of the Diane Havlir, Chair of the TB/HIV Working Group and co-chair of AIDS 2012, the IAS conference programme this year was packed full of TB/HIV. There was a record breaking number of well attended sessions focussing on TB, including late breakers, workshops, oral abstract sessions and satellite symposia, posters and global village activities. The TB coverage culminated in Friday’s superb plenary presentation given by Anthony Harries of the Union, followed by a special session on Looking to the Future in HIV and TB, with participation from the Core Group members, Diane Havlir, Richard Chaisson, Haileyesus Getahun and Mark Harrington. The meeting concluded with an impassioned call for action by Whoopi Goldberg to join together to tackle HV and TB as one disease. For webcasts and presentations of all the TB/HIV sessions at AIDS 2012, please visit the conference TB/HIV roadmap which provides links to all the sessions. For photos and articles surrounding the breaking science at AIDS 2012, please visit our Facebook page.

Programme Managers Skills Building Workshop at AIDS 2012, XIX International AIDS Conference
24 Jul 2012

24 July 2012 | Washington DC, USA,

As part of the AIDS 2012 conference WHO organised and facilitated the skills building workshop for National TB and HIV programme managers "TB/HIV Collaborative Activities - Implement, Integrate and Scale up to Prevent TB Deaths in People living with HIV!" on 24th July 2012. The workshop was attended some 200 participants and aimed to accelerate the global scale-up of collaborative TB/HIV activities through a regional cross fertilization of experience and best practice. HIV and NTP Programme Managers from Cambodia, Guyana, India, Kenya, Rwanda, South Africa, the People’s Republic of China and Ukraine presented on key challenges, bottle-necks and progress in implementation as well as enablers and measures needed to scale up TB/HIV collaborative activities and concluded with a civil society verbal commentary. For presentations and the meeting agenda please visit the links below.

Agenda | Presentations

Transforming the HIV/TB Response: Defining the next 10 years
21 Jul 2012

21 July, 2012 | Washington DC, USA

The World Health Organization, in collaboration with Georgetown University, organized a high level international consultation on behalf of the TB/HIV Working Group of the Stop TB Partnership, in conjunction with the AIDS 2012 conference in Washington DC on July 21, 2012. The aim of the meeting was to discuss innovative ideas and ways to define and shape the global TB/HIV response for the next decade. It also harvested experiences and identified key challenges and barriers in the scale-up of collaborative TB/HIV activities, including key research gaps. Co-hosted by Diane Havlir of the University of San Francisco and Chair of AIDS 2012 and the TB/HIV Working Group, and Mark Dybul of Georgetown University and George W Bush Institute and former US Global AIDS Coordinator, and convened by Haileyesus Getahun of the Stop TB Department of WHO, the meeting was attended by some 130 participants, including opinion leaders, global policy makers, leading scientists, activists and national HIV and TB programme managers. The morning session opened with presentations and a high level panel discussion comprising Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases, Gottfried Hirnschall, Director of WHO’s HIV/AIDS Department, Mark Harrington, Executive Director of Treatment Action Group, Debrework Zewdie, Deputy Executive Director of the Global Fund and Eric Goosby, the US Global AIDS Coordinator. Meeting participants also reviewed global and regional progress as well as key challenges and experiences in the scaling up collaborative TB/HIV activities, presented by Director of the Bureau of Disease Control’s Division of HIV/AIDS Prevention and Management of the People’s Republic China, Xia Gang, and by the National Programme Officer of the National AIDS Control Organisation of India, BB Rewari. New evidence, actions and prospects for the next ten years on prevention, diagnosis and treatment were presented by Richard Chaisson, Professor at Johns Hopkins University in Baltimore; Stephen Lawn, Reader in Infectious Diseases and Tropical Medicine at the London School of Hygiene and Tropical Medicine and Associate Professor at the University of Cape Town; and Moses Kamya, Associate Professor at Makerere University, Uganda. In addition, neglected areas such as childhood TB, HIV related TB in prisons and the convergence of drug use and hepatitis in drug users were presented by Soumya Swaminathan, Assistant Director of India’s Tuberculosis Research Centre; Stewart Reid, CIDZ’s Medical Director and Associate Professor with the University of Alabama at Birmingham; and Chris Beyrer, Associate Director of Public Health at Johns Hopkins Center for Global Health, respectively. For the meeting presentations and meeting agenda please visit the links below.

Agenda | Presentations

Resource for TB research and product development issues
20 Jul 2012

The Global Tuberculosis Community Advisory Board (TB CAB) is dedicated to increasing community involvement in TB research and to mobilizing political will regarding key TB product development issues. The TB CAB is comprised of research activists from all over the world, who are extensively involved in HIV and TB research networks. Read more about the TB CAB on their new website TB Online http://www.tbonline.info/ This website provides information for activists, patients health workers and researchers working to end tuberculosis.

World Tuberculosis Day joint message from the Directors of WHO HIV and Stop TB Departments
24 Mar 2012

The theme of this year’s World TB Day 2012 is "Stop TB in my lifetime" with a special focus on childhood TB. It is very clear we need to take full advantage of each and every approach and intervention available to us in order to achieve this inspiring goal.

One of the critical areas is the HIV/TB combined epidemics. HIV is not only a major risk factor for tuberculosis, but children with HIV are at markedly increased risk of TB. Just a month ago, we launched the updated WHO policy on collaborative TB/HIV activities. We estimate that nearly 1 million lives have been saved between 2005-2010 thanks to implementation of TB/HIV collaborative policies in countries. Thus, the importance of implementing the new Policy, and in particular, in addressing the needs of most-at-risk and key populations, such as women and children must be emphasized. Delivery of the Three I’s for HIV/TB (including isoniazid preventive treatment, infection control for TB, and intensified case finding for TB) and earlier antiretroviral treatment for eligible people, including women and children, can dramatically reduce the number of new cases, saving millions of lives in the coming years.

On this World TB Day 2012, the detrimental effects of HIV and TB on women and children need to be reiterated:

  • Pregnant women living with HIV are ten times more likely to develop active TB than those without HIV.
  • TB is a leading infectious cause of death during pregnancy and delivery, particularly among women living with HIV.
  • TB during pregnancy increases the risk that babies will be born prematurely or with a low birth weight.
  • TB in a pregnant woman living with HIV more than doubles the risk of vertical transmission of HIV to the unborn child.
  • Most children get TB from a family member.
  • In 2010, there were some 10 million children globally who were orphans because of TB among their parents.
  • TB is both preventable and curable in women and children, regardless of HIV status. The Three I’s for HIV/TB and earlier ART significantly reduce the risk of TB.

Today the Journal of Infectious Diseases has published a scientific review on the magnitude and challenges of maternal and childhood TB in high TB and HIV burden settings together with related recommendations for policy, programming and research. It provides further in-depth evidence on the scope of the problem, as well as opportunities we have at hand to overcome the challenges. Recommended actions are also outlined in the brochure: No More Crying, No More Dying. Towards Zero TB Deaths in Children which was released on Wednesday.

We would like to thank you and congratulate you - all our stakeholders - for the past success in addressing HIV/TB through collaboration. And we urge you to make every effort this year to ensure that collaborative TB/HIV activities become a firm and integral part of all HIV and TB services including, prevention of mother-to-child transmission programmes, prenatal care, family planning and immunization services. This would be an incredible step forward towards getting to zero TB deaths in children.